The Sygen® multicenter acute Spinal cord injury study

Randomized, double-blind, sequential, multicenter clinical trial of two doses of Sygen versus placebo. To determine efficacy and safety of Sygen in acute spinal cord injury. An earlier, single-center trial in 28 patients showed an improvement (50.0% vs. 7.1%, P = 0.034) in marked recovery with Sygen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Spine (Philadelphia, Pa. 1976) Pa. 1976), 2001-12, Vol.26 (24), p.S87-S100
Hauptverfasser:	GEISLER, Fred H, COLEMAN, William P, GRIEC, Giacinto, POONIAN, Devinder, FEHLINGS, Michael G, BRACKEN, Michael B
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adolescent Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Double-Blind Method Emergency and intensive care: injuries, diseases due to physical agents. Diving. Drowning. Disaster medicine Female G(M1) Ganglioside - analogs & derivatives G(M1) Ganglioside - therapeutic use Humans Intensive care medicine Logistic Models Male Medical sciences Middle Aged Neuropharmacology Neuroprotective agent Neuroprotective Agents - therapeutic use Pharmacology. Drug treatments Prospective Studies Recovery of Function Spinal Cord Injuries - drug therapy Spinal Cord Injuries - physiopathology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!